These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 31932428
1. Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis. Zhao Y, Yamasaki R, Yamaguchi H, Nagata S, Une H, Cui Y, Masaki K, Nakamuta Y, Iinuma K, Watanabe M, Matsushita T, Isobe N, Kira JI. Proc Natl Acad Sci U S A; 2020 Jan 28; 117(4):2160-2169. PubMed ID: 31932428 [Abstract] [Full Text] [Related]
2. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination. Une H, Yamasaki R, Nagata S, Yamaguchi H, Nakamuta Y, Indiasari UC, Cui Y, Shinoda K, Masaki K, Götz M, Kira JI. J Neuroinflammation; 2021 Jun 05; 18(1):126. PubMed ID: 34090477 [Abstract] [Full Text] [Related]
3. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Fang M, Yamasaki R, Li G, Masaki K, Yamaguchi H, Fujita A, Isobe N, Kira JI. Front Immunol; 2018 Jun 05; 9():2588. PubMed ID: 30464764 [Abstract] [Full Text] [Related]
4. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination. Papaneophytou CP, Georgiou E, Karaiskos C, Sargiannidou I, Markoullis K, Freidin MM, Abrams CK, Kleopa KA. Glia; 2018 Dec 05; 66(12):2589-2603. PubMed ID: 30325069 [Abstract] [Full Text] [Related]
5. Connexin 43/47 channels are important for astrocyte/ oligodendrocyte cross-talk in myelination and demyelination. Basu R, Sarma JD. J Biosci; 2018 Dec 05; 43(5):1055-1068. PubMed ID: 30541963 [Abstract] [Full Text] [Related]
6. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis. Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa KA. Glia; 2012 Jul 05; 60(7):1053-66. PubMed ID: 22461072 [Abstract] [Full Text] [Related]
7. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ. Glia; 2006 May 05; 53(7):696-703. PubMed ID: 16498619 [Abstract] [Full Text] [Related]
8. Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease. Olympiou M, Sargiannidou I, Markoullis K, Karaiskos C, Kagiava A, Kyriakoudi S, Abrams CK, Kleopa KA. Acta Neuropathol Commun; 2016 Sep 01; 4(1):95. PubMed ID: 27585976 [Abstract] [Full Text] [Related]
9. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. Mc Guire C, Volckaert T, Wolke U, Sze M, de Rycke R, Waisman A, Prinz M, Beyaert R, Pasparakis M, van Loo G. J Immunol; 2010 Dec 15; 185(12):7646-53. PubMed ID: 21068410 [Abstract] [Full Text] [Related]
10. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model. Georgiou E, Sidiropoulou K, Richter J, Papaneophytou C, Sargiannidou I, Kagiava A, von Jonquieres G, Christodoulou C, Klugmann M, Kleopa KA. Brain; 2017 Mar 01; 140(3):599-616. PubMed ID: 28100454 [Abstract] [Full Text] [Related]
11. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C. J Neurosci; 2004 Feb 11; 24(6):1521-9. PubMed ID: 14960625 [Abstract] [Full Text] [Related]
12. Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE. Stavropoulos F, Georgiou E, Sargiannidou I, Kleopa KA. Pharmaceuticals (Basel); 2021 Jun 28; 14(7):. PubMed ID: 34203192 [Abstract] [Full Text] [Related]
13. Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model. Takase EO, Yamasaki R, Nagata S, Watanabe M, Masaki K, Yamaguchi H, Kira JI, Takeuchi H, Isobe N. Sci Rep; 2024 May 13; 14(1):10877. PubMed ID: 38740862 [Abstract] [Full Text] [Related]
14. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response. Choi JH, Lee MJ, Jang M, Kim EJ, Shim I, Kim HJ, Lee S, Lee SW, Kim YO, Cho IH. PLoS One; 2015 May 13; 10(10):e0138592. PubMed ID: 26444423 [Abstract] [Full Text] [Related]
15. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity. Parenti R, Cicirata F, Zappalà A, Catania A, La Delia F, Cicirata V, Tress O, Willecke K. Glia; 2010 Oct 13; 58(13):1594-609. PubMed ID: 20578039 [Abstract] [Full Text] [Related]
16. Neurotropic Murine β-Coronavirus Infection Causes Differential Expression of Connexin 47 in Oligodendrocyte Subpopulations Associated with Demyelination. Das S, Shaw AK, Das Sarma S, Koval M, Das Sarma J, Maulik M. Mol Neurobiol; 2024 Sep 18. PubMed ID: 39292341 [Abstract] [Full Text] [Related]
17. Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via Mitigation of Glial Inflammation. Nagata S, Yamasaki R, Takase EO, Iida K, Watanabe M, Masaki K, Wijering MHC, Yamaguchi H, Kira JI, Isobe N. Biology (Basel); 2023 Sep 07; 12(9):. PubMed ID: 37759616 [Abstract] [Full Text] [Related]
18. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation. Di Bello IC, Dawson MR, Levine JM, Reynolds R. J Neurocytol; 1999 Sep 07; 28(4-5):365-81. PubMed ID: 10739577 [Abstract] [Full Text] [Related]
19. Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions. Li X, Penes M, Odermatt B, Willecke K, Nagy JI. Eur J Neurosci; 2008 Oct 07; 28(8):1503-17. PubMed ID: 18973575 [Abstract] [Full Text] [Related]
20. [Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease]. Masaki K. Rinsho Shinkeigaku; 2012 Oct 07; 52(11):1354-6. PubMed ID: 23196616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]